<DOC>
	<DOCNO>NCT01097902</DOCNO>
	<brief_summary>The experimental pain model study proposal show characteristic inflame wound pro-inflammatory response . This study help discover candidate genetic and/or proteomic pain biomarkers could provide objective mechanism base test diagnose , monitor quantify pain . We also hope determine measurable effect know non-steroidal anti-inflammatory drug ( NSAID ) biomarkers pain inflammation .</brief_summary>
	<brief_title>Study Experimental Models Pain Inflammation .</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>1 ) Age 1860 2 ) Skin type II III accord classification Fitzpatrick 3 ) Negative pregnancy test ( woman childbearing potential ) 4 ) Willing able sign inform consent form Health Insurance Portability Accountability Act ( HIPAA ) authorization comply study procedures 1 ) History acute chronic illness may hinder study procedure confuse interpretation data ( e.g . dermatological , neurological , psychiatric addictive disease ) 2 ) Clinically significant cardiovascular , pulmonary , hepatic renal disease 3 ) Major bodily injury within 3 month study participation 4 ) Surgery within 3 month study participation 5 ) Pregnancy breastfeed 6 ) Intake prescription drug anti/proinflammatory action 7 ) Intake prescription drug anti/proanalgesic action 8 ) Inability abstain anti/pro inflammatory drug 24hour period precede study session 9 ) Inability abstain anti/proanalgesic drug 24hour period precede study session 10 ) Prior medical history would contraindicate use NSAID , previous negative reaction NSAIDs aspirin 11 ) Inability obtain least 6 hour sleep night precede study session</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>